FDA Adverse Event Injury Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 11020711 · Received December 16, 2020

Report

Report Number
3004464228-2020-19754
Event Type
Injury
Date Received
December 16, 2020
Date of Event
December 9, 2020
Report Date
December 14, 2020
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120033
PMA / PMN Number
K192659
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE REPORTED HOSPITALIZATION AND HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD BEEN HOSPITALIZED WITH HYPERGLYCEMIA. THE PATIENT'S BLOOD GLUCOSE LEVELS REACHED OVER 250 MG/DL WHILE WEARING THE POD. SYMPTOMS REPORTED INCLUDE HYPERGLYCEMIA AND CONFUSION. ONCE AT THE HOSPITAL THE PATIENT WAS TREATED (TREATMENT UNKNOWN). THE PATIENT WAS RELEASED FROM THE HOSPITAL AFTER 5 DAYS. THE PATIENT WAS PRESCRIBED CEFUROXIME (500 MG X 2) TO BE TAKEN FOR 7 DAYS, ELIQUIS (5 MG X 1) TO BE TAKEN EVERY 12 HOURS FOR 30 DAYS, PACERONE (200 MG X 1) TO BE TAKEN 2 TIMES A DAY AND METOPROLOL (25 MG X 1) TO BE TAKEN EVERY 12 HOURS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1489236 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 19191 L71073 20385081120033

Patients

Seq Age Sex Outcome Treatment
1 52 YR Hospitalization